Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.42 USD | +1.95% | +4.88% | -8.96% |
May. 02 | Avanos Medical to Seek M&A Opportunities | CI |
May. 02 | Transcript : Avanos Medical, Inc., Q1 2024 Earnings Call, May 02, 2024 |
Financials (USD)
Sales 2024 * | 695M | Sales 2025 * | 730M | Capitalization | 881M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 1.27 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.21 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 3,771 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.1% |
Latest transcript on Avanos Medical, Inc.
1 day | +1.95% | ||
1 week | +4.88% | ||
Current month | +12.94% | ||
1 month | +9.49% | ||
3 months | +6.41% | ||
6 months | -4.62% | ||
Current year | -8.96% |
Managers | Title | Age | Since |
---|---|---|---|
Joseph Woody
CEO | Chief Executive Officer | 58 | 17-06-25 |
Michael Greiner
DFI | Director of Finance/CFO | 51 | 19-12-31 |
Compliance Officer | - | 20-09-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gary Blackford
CHM | Chairman | 66 | 14-10-30 |
Patrick O'Leary
BRD | Director/Board Member | 66 | 14-10-30 |
Julie Shimer
BRD | Director/Board Member | 71 | 14-10-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.42% | 25 M€ | -1.18% | - | |
0.19% | 43 M€ | +4.31% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 20.42 | +1.95% | 171,749 |
24-05-15 | 20.03 | -0.30% | 136,263 |
24-05-14 | 20.09 | +1.06% | 148,705 |
24-05-13 | 19.88 | +1.53% | 144,129 |
24-05-10 | 19.58 | +0.56% | 138,609 |
Delayed Quote Nyse, May 16, 2024 at 04:00 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-8.96% | 881M | |
-4.72% | 182B | |
+3.96% | 114B | |
-2.93% | 68.38B | |
+6.30% | 52.46B | |
+8.02% | 44.25B | |
+7.52% | 43.55B | |
+26.18% | 32.69B | |
+17.85% | 26.73B | |
+0.57% | 25.79B |
- Stock Market
- Equities
- AVNS Stock